Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride
Pricing Report NDC 45802-721-53

Latest NADAC: $0.55997 per EA · Effective Apr 20, 2022 · Est. package price $6.72 (12 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 45802-721-53) is $0.55997 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 20, 2022.

As a provided by Padagis Israel Pharmaceuticals Ltd, this medication is distributed in a 12 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.55997
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 20, 2022
Billable Units
12 EA
Estimated Package Price
$6.72
Data Status
As of Apr 27, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
45802-721-53
Description
12 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.55716 to $0.77503 per EA. Over this 8 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5572 - $0.7750
Market Volatility
39.10% Variance
Latest Trend
4.79%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
May 18, 2022 $0.58681 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 20, 2022 $0.55997 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 20, 2022 $0.55997 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 23, 2022 $0.59854 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 23, 2022 $0.59854 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 23, 2022 $0.59913 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 23, 2022 $0.59913 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 19, 2022 $0.61621 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 19, 2022 $0.61621 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 22, 2021 $0.58635 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 22, 2021 $0.58635 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 17, 2021 $0.61479 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026